Ultragenyx Pharmaceutical
RARE
RARE
232 hedge funds and large institutions have $5.69B invested in Ultragenyx Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 95 increasing their positions, 70 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $6.01B → $5.69B (-$325M)
89% less call options, than puts
Call options by funds: $874K | Put options by funds: $8.01M
Holders
232
Holding in Top 10
–
Calls
$874K
Puts
$8.01M
Top Buyers
| 1 | +$115M | |
| 2 | +$40.8M | |
| 3 | +$34.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$31M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$20.6M |
Top Sellers
| 1 | -$247M | |
| 2 | -$24.8M | |
| 3 | -$21.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$12M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$9.77M |